Galapagos NV
GLPG
#5063
Rank
C$2.61 B
Marketcap
C$38.88
Share price
0.00%
Change (1 day)
-7.59%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): C-$0.76

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.57. In 2025 the company made an earnings per share (EPS) of C$8.02 an increase over its 2024 EPS that were of C$1.63.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.76-109.47%
2025C$8.02390.86%
2024C$1.63-67.16%
2023C$4.98-199.64%
2022C-$4.9999.03%
2021C-$2.51-68.98%
2020C-$8.09-298.06%
2019C$4.08-554.64%
2018C-$0.90-77.18%
2017C-$3.94-326.21%
2016C$1.74-134.19%
2015C-$5.09-371.34%
2014C$1.88-445.98%
2013C-$0.5432.88%
2012C-$0.41-82.07%
2011C-$2.28-817.9%
2010C$0.3212.73%
2009C$0.28-120.79%
2008C-$1.35-37.67%
2007C-$2.1739.64%
2006C-$1.5528.17%
2005C-$1.216.25%
2004C-$1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.25-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.06-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.88-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.59-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$4.99-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.74-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$5.45-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C-$0.86 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.92-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel